BNP Paribas Financial Markets’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.33M | Buy |
24,431
+11,076
| +83% | +$1.01M | ﹤0.01% | 2691 |
|
|
2026
Q1 | $1.29M | Buy |
13,355
+6,872
| +106% | +$687K | ﹤0.01% | 2965 |
|
|
2025
Q4 | $631K | Buy |
6,483
+1,394
| +27% | +$120K | ﹤0.01% | 3442 |
|
|
2025
Q3 | $362K | Sell |
5,089
-9,555
| -65% | -$637K | ﹤0.01% | 3727 |
|
|
2025
Q2 | $876K | Sell |
14,644
-4,657
| -24% | -$255K | ﹤0.01% | 2989 |
|
|
2025
Q1 | $1.01M | Sell |
19,301
-1,837
| -9% | -$103K | ﹤0.01% | 2777 |
|
|
2024
Q4 | $1.16M | Buy |
21,138
+477
| +2% | +$25.1K | ﹤0.01% | 2723 |
|
|
2024
Q3 | $1.04M | Buy |
20,661
+5,863
| +40% | +$270K | ﹤0.01% | 2475 |
|
|
2024
Q2 | $650K | Sell |
14,798
-2,290
| -13% | -$97.4K | ﹤0.01% | 2522 |
|
|
2024
Q1 | $752K | Buy |
17,088
+9,948
| +139% | +$440K | ﹤0.01% | 2640 |
|
|
2023
Q4 | $339K | Sell |
7,140
-7,164
| -50% | -$301K | ﹤0.01% | 3010 |
|
|
2023
Q3 | $635K | Buy |
14,304
+3,432
| +32% | +$159K | ﹤0.01% | 2590 |
|
|
2023
Q2 | $519K | Buy |
10,872
+3,340
| +44% | +$151K | ﹤0.01% | 2563 |
|
|
2023
Q1 | $296K | Buy |
7,532
+4,185
| +125% | +$152K | ﹤0.01% | 2988 |
|
|
2022
Q4 | $94.7K | Sell |
3,347
-268
| -7% | -$7.67K | ﹤0.01% | 3269 |
|
|
2022
Q3 | $109K | Buy |
3,615
+1,871
| +107% | +$65.2K | ﹤0.01% | 3732 |
|
|
2022
Q2 | $59.2K | Sell |
1,744
-1,507
| -46% | -$54K | ﹤0.01% | 3515 |
|
|
2022
Q1 | $146K | Buy |
3,251
+999
| +44% | +$46.2K | ﹤0.01% | 3235 |
|
|
2021
Q4 | $104K | Buy |
2,252
+1,157
| +106% | +$46.7K | ﹤0.01% | 3587 |
|
|
2021
Q3 | $36.8K | Buy |
1,095
+677
| +162% | +$23K | ﹤0.01% | 3579 |
|
|
2021
Q2 | $12.3K | Sell |
418
-320
| -43% | -$8.82K | ﹤0.01% | 3671 |
|
|
2021
Q1 | $19K | Sell |
738
-412
| -36% | -$9.84K | ﹤0.01% | 3767 |
|
|
2020
Q4 | $26.2K | Sell |
1,150
-257
| -18% | -$5.94K | ﹤0.01% | 3790 |
|
|
2020
Q3 | $30.1K | Buy |
1,407
+967
| +220% | +$21.7K | ﹤0.01% | 3680 |
|
|
2020
Q2 | $10.2K | Sell |
440
-974
| -69% | -$20.9K | ﹤0.01% | 3699 |
|
|
2020
Q1 | $30.2K | Buy |
1,414
+783
| +124% | +$18.6K | ﹤0.01% | 3772 |
|
|
2019
Q4 | $14.8K | Sell |
631
-3
| -0.5% | -$70 | ﹤0.01% | 4072 |
|
|
2019
Q3 | $13.3K | Buy |
634
+218
| +52% | +$4.45K | ﹤0.01% | 4096 |
|
|
2019
Q2 | $8.51K | Sell |
416
-349
| -46% | -$8.22K | ﹤0.01% | 4136 |
|
|
2019
Q1 | $21.5K | Buy |
765
+703
| +1,134% | +$18.4K | ﹤0.01% | 3887 |
|
|
2018
Q4 | $1.52K | Sell |
62
-52
| -46% | -$1.4K | ﹤0.01% | 3851 |
|
|
2018
Q3 | $4.24K | Sell |
114
-1
| -0.9% | -$27 | ﹤0.01% | 4120 |
|
|
2018
Q2 | $2.39K | Buy |
115
+114
| +11,400% | +$2.02K | ﹤0.01% | 4230 |
|
|
2018
Q1 | $14 | Hold |
1
| – | – | ﹤0.01% | 4188 |
|
|
2017
Q4 | $15 | Hold |
1
| – | – | ﹤0.01% | 4185 |
|
|
2017
Q3 | $10 | Hold |
1
| – | – | ﹤0.01% | 4211 |
|
|
2017
Q2 | $9 | Sell |
1
-77
| -99% | -$657 | ﹤0.01% | 4233 |
|
|
2017
Q1 | $694 | Sell |
78
-173
| -69% | -$1.6K | ﹤0.01% | 3779 |
|
|
2016
Q4 | $2.79K | Sell |
251
-24
| -9% | -$258 | ﹤0.01% | 3862 |
|
|
2016
Q3 | $4.67K | Buy |
275
+115
| +72% | +$2.13K | ﹤0.01% | 3398 |
|
|
2016
Q2 | $3.48K | Buy |
160
+33
| +26% | +$594 | ﹤0.01% | 3384 |
|
|
2016
Q1 | $2.43K | Sell |
127
-303
| -70% | -$5.8K | ﹤0.01% | 2379 |
|
|
2015
Q4 | $12.1K | Sell |
430
-128
| -23% | -$3.62K | ﹤0.01% | 3381 |
|
|
2015
Q3 | $13.6K | Buy |
558
+324
| +138% | +$7.75K | ﹤0.01% | 3390 |
|
|
2015
Q2 | $5.45K | Buy |
+234
| New | +$4.28K | ﹤0.01% | 3421 |
|
Other funds holding IRMD
CCM
NTCM
BNP Paribas Financial Markets's IRMD Position: Q2 2026 in Review
BNP Paribas Financial Markets increased its iRadimed (IRMD) stake by 83% in Q2 2026, buying an estimated $1.01M and bringing the position to 24,431 shares worth $2.33M. The position accounts for ﹤0.01% of the portfolio, ranked #2691.
BNP Paribas Financial Markets first reported a position in IRMD in Q2 2015 and has held it in 45 quarters since. 211 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- BNP Paribas Financial Markets held 24,431 shares of iRadimed worth $2.33M as of Q2 2026.
- BNP Paribas Financial Markets bought 11,076 iRadimed shares in Q2 2026, an estimated $1.01M.
- iRadimed made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2691 holding.
- BNP Paribas Financial Markets first reported a position in iRadimed in Q2 2015 and has held it in 45 quarters since.
- 211 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.